Barry, OppHub America Desk · · Source: prnewswire-all
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsu
Based on reporting from prnewswire-all.
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law News provided by Schall, Brown & Schwartz LLP Aug 13, 2026, 05:04 ET Share this article Share to X Share this article Share to X LOS ANGELES , Aug.
Market context for this story
As of: PremarketLoading quotes…
Informational only — not investment advice. Full markets →
$CAPR$CAPR
TradingView
Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice
Educational TradingView chart — search any symbol in the widget. Confirm on /markets/CAPR. Not investment advice.
Related markets
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
it with SBS Law News provided by Schall, Brown & Schwartz LLP Aug 13, 2026, 05:04 ET Share this article Share to X Share this article Share to X LOS ANGELES , Aug. 13, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Shareholders who purchased shares of $CAPR+WL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Trade this story
Robinhood
Webull
Tradier
IBKR
Chart this story
TradingView
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure
Story playbook
A pre-built map of what to watch — stocks, ETFs, and educational next steps. Not personalized advice.
Snapshot date: August 13, 2026 at 5:25 AM ET
This playbook was built when the story published and is not live-updated. Prices, news, and risk can change after this date — treat it as a starting map, not a current trade ticket.
Story → money map
Biotech Litigation Risk
A law firm is organizing a lawsuit against drug maker Capricor Therapeutics on behalf of unhappy investors. People who own the stock are worried about losing money due to potential deception.
What changed
A securities fraud class action lawsuit was announced against Capricor Therapeutics.
Who wins / who loses
Plaintiff law firms and short sellers benefit from heightened scrutiny, while current retail and institutional shareholders absorb sudden downside pressure.
Time horizon
Think in terms of next few days.
Confidence & best fit
high confidence · Active trader
Safer theme exposure (ETFs)
Baskets that own the theme without betting on one company.
Single stocks (higher risk)
Primary = closest to the story · Peers = same industry · Second-order = knock-on effects · Avoid = looks related but may be a trap
Primary
- $CAPRStay away — for now
The company is being sued by its own investors, making the stock very risky to hold right now.
View $CAPR chart → · End-of-day delayed data
Options (education only)
No strikes or expiries — a framework for how traders might express the view. Options can expire worthless.
Direction: volatile · Style: Protective put / downside hedge idea · Level: intermediate
Beginners should skip options here entirely, as legal news makes stock movements unpredictable and expensive to trade.
Income / OppHub America angle
Not a trade tip — ways to use the insight outside the market.
- Monitor corporate disclosures and SEC filings for updates regarding the class action timeline.
What would break this thesis
- Dismissal of the lawsuit or a strong positive clinical catalyst that overrides legal concerns.
What to do next on OppHub America
Saved playbooks stay on this device for now.
Important
Not financial advice. OppHub America playbooks are educational market maps only — not recommendations to buy, sell, or hold any security. Markets move fast; information can be wrong or outdated. Trade and invest at your own risk. Do your own research or consult a licensed advisor.
Based on reporting from prnewswire-all.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).